98%
921
2 minutes
20
Hypovolemic shock and hemorrhage continue to shape healthcare delivery and incur a heavy burden on public health and wellbeing. Many healthcare organizations have specific transfusion protocols that are referenced when a patient meets certain physiological criteria. These protocols are shaped around best practices and nuanced understanding of the physiology of the patient. Despite their importance, these protocols are extremely difficult to change or challenge and, to date, there does not exist a sufficient mathematical model that may be employed towards investigating simulated patient hemorrhage. We show that once constructed, we can consider the health of the patient in phase-space rather than traditional time-series representations, quantifying the recovery of the patient due to the geometry of the trajectories. We construct a whole-body physiology model of hemorrhagic shock and trauma that encompasses multiple organ systems, non-linear feedback mechanisms and patient variability. We validate this model by constructing a major hemorrhage scenario, that includes transit time and associated mass transfusion resuscitation of the patient. We then use this model to create phase-plane diagrams of patient trajectories as a function of lactate blood pH and volumes, among other relevant physiological metrics. Exploring these patient trajectories amongst a varied patient population yields a series of high curvature points associated with the transition from deterioration to recovery of the patient. We then construct a convex hull, covering the high curvature regions of a diverse simulated patient population. These hulls, constructed by simulated numerous patients, exposed to three distinct hemorrhagic severities, are then used to validate the model by comparing experimental serum lactate levels as a function of blood volume to these regions in phase-space. In conclusion, we show that the model is highly accurate and accounts for distinct lactate trajectories amongst the simulated patient cohorts. Finally, we fit a logistic curve to the resulting data for a quick patient severity tool and denote the standard error of parameterization based on the delta method.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12360659 | PMC |
http://dx.doi.org/10.1371/journal.pcbi.1012820 | DOI Listing |
Br J Haematol
September 2025
Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Refractory cytomegalovirus (CMV) infection is a severe complication following umbilical cord blood transplantation (UCBT). Antiviral agents, the standard first-line therapy, are limited by toxicity and resistance without robust T-cell immunity. We evaluated third-party donor (TPD)-derived CMV-specific T cells (CMVSTs) as a treatment option.
View Article and Find Full Text PDFJPEN J Parenter Enteral Nutr
September 2025
Center for Sarcopenia and Malnutrition Research, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
Background: Limited evidence exists regarding the cognitive and physical improvement effects of medium-chain triglyceride (MCT) intake in patients with stroke. This study aimed to investigate the association between MCT-enhanced rice consumption and enhancements in outcomes, including cognitive level, in patients following stroke.
Methods: We performed a retrospective cohort study on adults admitted to a rehabilitation center with cognitive decline following acute stroke.
J Dermatolog Treat
December 2025
Department of Dermatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Background: Bullous pemphigoid (BP) is a common autoimmune subepidermal bullous disease. Dupilumab, an IL-4/IL-13 inhibitor, represents a novel therapeutic approach for BP, but real-world long-term data in super-elderly patients are limited.
Methods: This retrospective, single-center observational study included super-elderly BP patients (≥80 years) receiving dupilumab monotherapy from September 2022 to September 2024.
Nutr Clin Pract
September 2025
Department of Clinical Nutrition, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Objective: The cachexia index (CXI) demonstrates potential as both a diagnostic tool for cachexia and a prognostic tool for survival in cancer. However, CXI's predictive value has not been verified in cervical cancer. The purpose of this study is to investigate the prognostic value of the CXI in patients with cervical cancer treated with radiotherapy.
View Article and Find Full Text PDFJPEN J Parenter Enteral Nutr
September 2025
Department of Gastroenterology, Austin Health, Heidelberg, Victoria, Australia.
Background: Hospitalized patients may require nutrition support because of inadequate intake or impaired gut function. Enteral nutrition is preferred over parenteral nutrition because of fewer complications and earlier return of gut function. This study describes peripheral parenteral nutrition (PPN) use in an Australian tertiary center, evaluating its indications, incidence of adverse effects, and outcomes without the support of a nutrition support service.
View Article and Find Full Text PDF